D.C. Mun. Regs. tit. 22, r. 22-B1204

Current through Register Vol. 71, No. 49, December 6, 2024

Rule 22-B1204 - SCHEDULE IV ENUMERATED

1204.1

The controlled substances listed in this section are included in Schedule IV of the Act unless removed therefrom pursuant to Section 201 of the Act. Schedule IV shall consist of the following controlled substances:

(a) Depressants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

(1) Alfaxalone;

(2) Alprazolam;

(3) Barbital;

(4) Bromazepam;

(5) Camazepam;

(6) Chloral betaine;

(7) Chloral hydrate;

(8) Chlordiazepoxide;

(9) Clobazam;

(10) Clonazepam;

(11) Clorazepate;

(12) Clotiazepam;

(13) Cloxazolam;

(14) Delorazepam;

(15) Diazepam;

(16) Dichloralphenazone;

(17) Estazolam;

(18) Ethyl loflazepate;

(19) Ethchlorvynol;

(20) Ethinamate;

(21) Fludiazepam;

(22) Flunitrazepam;

(23) Flurazepam;

(24) Fospropofol;

(25) Halazepam;

(26) Haloxazolam;

(27) Ketazolam;

(28) Loprazolam;

(29) Lorazepam;

(30) Lormetazepam;

(31) Mebutamate;

(32) Medazepam;

(33) Meprobamate;

(34) Methohexital;

(35) Methylphenobarbital (mephobarbital);

(36) Midazolam;

(37) Nimetazepam;

(38) Nitrazepam;

(39) Nordiazepam;

(40) Oxazepam;

(41) Oxazolam;

(42) Paraldehyde;

(43) Petrichloral;

(44) Phenobarbital;

(45) Pinazepam;

(46) Prazepam;

(47) Quazepam;

(48) Temazepam;

(49) Tetrazepam; and

(50) Triazolam;

(b) Fenfluramine: Any material, compound, mixture, or preparation that contains any quantity of the following substances, including its salts, isomers, (whether optical, position, or geometric), and salts of such isomers, whenever the existence of the salts, isomers, and salts of isomers is possible: Fenfluramine;

(c) Stimulants: Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of the salts, isomers and salts of isomers is possible within the specific chemical designation:

(1) Cathine;

(2) Clortermine;

(3) Dexfenfluramine;

(4) Diethylpropion;

(5) Fencamfamin;

(6) Fenproporex;

(7) Lorcaserin;

(8) Mazindol;

(9) Mefenorex;

(10) Modafinil;

(11) Pemoline (including organometallic complexes and chelates thereof);

(12) Phentermine;

(13) Pipradrol;

(14) Sibutramine; and

(15) SPA;

(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances, including its salts:

(1) Butorphanol;

(2) Dextropropoxyphene (Alpha-(+)-4-demethylamino-1), 2-diphenyl-1-3-methyl-2-propionoxybutane; and

(3) Pentazocine;

(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof of not more than one (1) milligram of difenoxin and not less than twenty-five (25) micrograms of atropine sulfate per dosage unit;

(f) Carisoprodol;

(g) Zaleplon;

(h) Zolpidem;

(i) Zopiclone;

(j) Suvorexant;

(k) Tramadol;

(l) Brotizolam; 3-(2- bromophenyl)-4-[(3-chlorophenyl)methylideneamino]-1H-1,2,4-triazole-5-thione;

(m) Vinylbital; (Vinylbitone; Vinylbitalum;);

(n) Mesocarb;

(o) Dezocine;

(p) Allobarbital; Allobarbitone;

(q) (Phenazepam) 7-bromo-5-(2-chlorophenyl)-1,3,dihydro-2H-1,4-benzodiazepin-2-one;

(r) 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno-[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine (#) 7-bromo-5-(2-chlorophenyl)- 1H-benzo[e][1,4]diazepin-2(3H)-one(#) 8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine;

(s) 3-methyl-6-[3-(trifluoromethyl)phenyl][1,2,4]triazol[4,3-b]pyridazine; and

(t) 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-oxo-5H-pyrrolo[3,4- b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate.

D.C. Mun. Regs. tit. 22, r. 22-B1204

Final Rulemaking published at 39 DCR 1882, 1888 (March 20, 1992); Notice of Emergency and Proposed Rulemaking published at 47 DCR 7512 (September 15, 2000) [EXPIRED]; as amended by Final Rulemaking published at 48 DCR 914 (February 2, 2001); as amended by Notice of Emergency and Proposed Rulemaking published at 50 DCR 10421 (December 5, 2003) [EXPIRED]; as amended by Final Rulemaking published at 51 DCR 4080 (April 23, 2004); as amended by Final Rulemaking published at 61 DCR 10233 (October 3, 2014); amended by Final Rulemaking published at 63 DCR 014819 (12/2/2016)